Abstract:Background: Sevoflurane and propofol are effective cardioprotective anaesthetic agents, though the cardioprotection of propofol has not been shown in humans. Their roles and underlying mechanisms in anesthetic postconditioning are unclear. Mitochondrial permeability transition pore (MPTP) opening is a major cause of ischemia-reperfusion injury. Here we investigated sevoflurane-and propofol-induced postconditioning and their relationship with MPTP. Methods: Isolated perfused rat hearts were exposed to 40 min of ischemia followed by 1 h of reperfusion. During the first 15 min of reperfusion, hearts were treated with either control buffer (CTRL group) or buffer containing 20 μmol/L atractyloside (ATR group), 3% (v/v) sevoflurane (SPC group), 50 μmol/L propofol (PPC group), or the combination of atractyloside with respective anesthetics (SPC+ATR and PPC+ATR groups). Infarct size was determined by dividing the total necrotic area of the left ventricle by the total left ventricular slice area (percent necrotic area). Results: Hearts treated with sevoflurane or propofol showed significantly better recovery of coronary flow, end-diastolic pressures, left ventricular developed pressure and derivatives compared with controls. Sevoflurane resulted in more protective alteration of hemodynamics at most time point of reperfusion than propofol. These improvements were paralleled with the reduction of lactate dehydrogenase release and the decrease of infarct size (SPC vs CTRL: (17.48±2.70)% vs (48.47±6.03)%, P<0.05; PPC vs CTRL: (35.60±2.10)% vs (48.47±6.03)%, P<0.05). SPC group had less infarct size than PPC group (SPC vs PPC: (17.48±2.70)% vs (35.60±2.10)%, P<0.05). Atractyloside coadministration attenuated or completely blocked the cardioprotective effect of postconditioning of sevoflurane and propofol. Conclusion: Postconditioning of sevoflurane and propofol has cardioprotective effect against ischemia-reperfusion injury of heart, which is associated with inhibition of MPTP opening. Compared to propofol, sevoflurane provides superior protection of functional recovery and infarct size.

Research progress of the protective mechanism of sevoflurane on ischemic brain injury

Effect of sevoflurane on learning and memory and related mechanisms

Recent Progress in Neuroprotective Effects of Sevoflurane Preconditioning:Molecular Mechanisms

Protective effects of sevoflurane in cerebral ischemia reperfusion injury: a narrative review

Neuroprotections and Mechanisms of Inhalational Anesthetics Against Brain Ischemia.

Postconditioning with Sevoflurane Protects Against Focal Cerebral Ischemia and Reperfusion Injury Via Pi3k/Akt Pathway

Protective Mechanism of Sevoflurane Against Cerebral Ischemia-Reperfusion Induced Injury

[Neuroprotection of Sevoflurane Against the Ischemia Injury in Hippocampal Slices of Rat].

The effect of pre- and after-treatment of sevoflurane on central ischemia tolerance and the underlying mechanisms.

Inhaled Anesthetic Sevoflurane: Neurotoxicity or Neuroprotection in the Developing Brain

Progression in the study of protective effect of microRNAs against sevoflurane-induced postoperative cognitive dysfunction and potential mechanisms

The Mechanisms of Sevoflurane-Induced Neuroinflammation

Sevoflurane:harm or Protection to a Developing Brain

Postconditioning of Sevoflurane and Propofol is Associated with Mitochondrial Permeability Transition Pore

Sevoflurane-induced delayed neuroprotection involves mitoK ATP channel opening and PKC ε activation

Protective Effect of Enflurane, Isoflurane and Sevoflurane on Brain Ischemia in Rat

Sevoflurane: an opportunity for stroke treatment

Protective effects and mechanisms of sevoflurane on anoxia injuryin cultured rat hippocampal neurons

Neuroprotection Provided by Isoflurane Pre-Conditioning and Post-Conditioning

Effects of Isoflurane and Sevoflurane Postconditioning and Changes in Jnk1/2 Pathway Activity on Rat Brain Slices Subjected to Oxygen and Glucose Deprivation in Vitro

Sevoflurane Preconditioning Protects Blood-Brain-barrier Against Brain Ischemia.